News Center
News and information
Shanghai Genebio officially expanded its biopharmaceutical control business
As we all know, biological agents are the fastest growing field in the pharmaceutical industry.In 2019, seven of the top ten best-selling drugs in the world are biological agents.Biological products include recombinant proteins, vaccines, and specific monoclonal antibodies.Related studies have shown that the rDNA of host cells in biological products has potential oncogenic and infectious risks.It may also cause gene insertion mutation, so detection of rDNA content is related to the quality and purity of biological products, and is an important indicator of product quality and safety.
Forensic DNA extraction kits (silicon bead method and magnetic bead method) developed by Shanghai Genebio has reached a considerable level.Forensic DNA extraction kits are biased towards factors such as anti-interference, anti-inhibition, trace,etc.While cellular residual DNA extraction kits focus on factors such as high sensitivity, high recovery,etc.At the same time, Shanghai Genebio also has matching domestic automatic extraction workstation, which can be used to compile corresponding extraction program according to different kits.
During the process of developing forensic individual identification detection kit and novel coronavirus detection kit, our company has gained considerable knowledge of qPCR detection platform and formed a continuously optimized reaction system of our own.We have mature productive technology and material-supplying way.The system platform can be quickly applied to development of residual DNA detection kit.
Back list
Array
(
[id] => 60
[lm] => 26
[title] => Shanghai Genebio took part in an exhibition of the second scientific conference on biopharmaceutical quality for the first time
)
Prev
Next